Phosphodiesterase 4 and its inhibitors in inflammatory diseases
about
The cAMP Pathway as Therapeutic Target in Autoimmune and Inflammatory DiseasesSelective Phosphodiesterase 4B Inhibitors: A ReviewInhibition of phosphodiesterase 4 reduces ethanol intake and preference in C57BL/6J micePharmacophore modeling and virtual screening for the discovery of new type 4 cAMP phosphodiesterase (PDE4) inhibitorsRelaxant and anti-inflammatory effect of two thalidomide analogs as PDE-4 inhibitors in pregnant rat uterusThe unrecognized effects of phosphodiesterase 4 on epithelial cells in pulmonary inflammation.Reduction of alcohol drinking of alcohol-preferring (P) and high-alcohol drinking (HAD1) rats by targeting phosphodiesterase-4 (PDE4).Apremilast, a novel phosphodiesterase 4 (PDE4) inhibitor, regulates inflammation through multiple cAMP downstream effectors.Therapeutic benefits of phosphodiesterase 4B inhibition after traumatic brain injury.Phosphodiesterase 4 inhibition in the treatment of psoriasis, psoriatic arthritis and other chronic inflammatory diseases.Anchored PDE4 regulates chloride conductance in wild-type and ΔF508-CFTR human airway epithelia.Clinical and molecular genetics of the phosphodiesterases (PDEs).Systemic administration of propentofylline, ibudilast, and (+)-naltrexone each reverses mechanical allodynia in a novel rat model of central neuropathic pain.Phosphodiesterase 4B negatively regulates endotoxin-activated interleukin-1 receptor antagonist responses in macrophages.Phosphodiesterase inhibitors as therapeutics for traumatic brain injury.PDE4 Inhibition and Inflammatory Bowel Disease: A Novel Therapeutic Avenue.siRNA-mediated silencing of phosphodiesterase 4B expression affects the production of cytokines in endotoxin-stimulated primary cultured microglia.Effects of early rolipram treatment on histopathological outcome after controlled cortical impact injury in mice.Pharmacophore Based Virtual Screening Approach to Identify Selective PDE4B Inhibitors.Phosphodiesterase type 5 and cancers: progress and challenges.Paper-based inkjet bioprinting to detect fluorescence resonance energy transfer for the assessment of anti-inflammatory activity.Apremilast Alters Behavioral Responses to Ethanol in Mice: I. Reduced Consumption and Preference.
P2860
Q26750377-414782A5-3AC0-4463-BFC9-B506C793B621Q28081071-8715DEA9-D2E0-4981-8C7E-CA71367C7EC0Q28386651-29025F22-915F-43F5-AE31-A15751C7DE5AQ28536716-8940FF05-4A58-40A9-B9AB-3E5F57468486Q33899061-7B5372EB-F5A8-4BDC-BF4F-E6642B67814EQ35536563-625A25B8-7CBC-4D1E-AC4B-FAB0F218507DQ35738103-CDAA6C82-3478-4587-9BA0-36AA59390CC8Q36061710-A6072381-E48C-40A5-BCD4-1169D663928AQ36380305-8F2DFED0-E644-4F70-98FF-03465B51F2FAQ36923514-B08517DF-A3F3-48B8-AD3F-613D199C4FFDQ37503665-2960F2D1-5CF1-4422-8559-0500D3163BF4Q37657841-686B0FB9-06A4-44F8-9FC4-0EC6CC56E983Q37678477-42A2D70C-8663-40EA-86F7-9D731362CCD7Q37739683-34CC0F12-2015-4519-A195-C3D07D99F195Q38243490-51C5CBE1-72D9-47C1-B519-B313875E70C1Q39375417-1CB8F16E-4A05-4760-9DE3-822AD98CA2FDQ41194095-D6E3F113-7D2C-4939-A98F-B387CFB9D1D5Q42424556-FE71C6B2-45EA-4BE2-813A-963F2289ECEEQ46212027-DD83A750-7B77-42E6-8D8F-FE6775C3A787Q47171803-C99C0F13-633E-4E0A-9881-0822BA2DC93EQ48043253-E4F566FF-926F-4414-BF93-1914418B03E4Q51749016-E0E2FD57-C7A0-4055-8CFA-37B1C3CE90E1
P2860
Phosphodiesterase 4 and its inhibitors in inflammatory diseases
description
2012 nî lūn-bûn
@nan
2012 թուականին հրատարակուած գիտական յօդուած
@hyw
2012 թվականին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Phosphodiesterase 4 and its inhibitors in inflammatory diseases
@ast
Phosphodiesterase 4 and its inhibitors in inflammatory diseases
@en
Phosphodiesterase 4 and its inhibitors in inflammatory diseases
@nl
type
label
Phosphodiesterase 4 and its inhibitors in inflammatory diseases
@ast
Phosphodiesterase 4 and its inhibitors in inflammatory diseases
@en
Phosphodiesterase 4 and its inhibitors in inflammatory diseases
@nl
prefLabel
Phosphodiesterase 4 and its inhibitors in inflammatory diseases
@ast
Phosphodiesterase 4 and its inhibitors in inflammatory diseases
@en
Phosphodiesterase 4 and its inhibitors in inflammatory diseases
@nl
P2093
P3181
P356
P1476
Phosphodiesterase 4 and its inhibitors in inflammatory diseases
@en
P2093
S-L Catherine Jin
Shiau-Li Ding
Shih-Chang Lin
P304
P3181
P356
10.4103/2319-4170.106152
P407
P577
2012-01-01T00:00:00Z